Literature DB >> 4074619

Enhanced weal and flare response to histamine in chronic idiopathic urticaria.

L B Krause, S Shuster.   

Abstract

Weal and flare histamine dose-responses were measured in 30 normal subjects and 15 patients with chronic idiopathic urticaria. The log dose-response curves were shifted to the left corresponding to an increase in histamine potency of 2.5 for weal and 3.1 for flare. An enhanced response to histamine may be important in chronic idiopathic urticaria and comparison of potency of antihistamines in different subjects may be unreliable where initial weal response is abnormal.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4074619      PMCID: PMC1400705          DOI: 10.1111/j.1365-2125.1985.tb05103.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  7 in total

1.  Inhibitory activity of terfenadine on histamine-induced skin wheals in man.

Authors:  K J Hüther; G Renftle; N Barraud; J T Burke; J Koch-Weser
Journal:  Eur J Clin Pharmacol       Date:  1977-11-14       Impact factor: 2.953

2.  H1-receptor-active histamine not sole cause of chronic idiopathic urticaria.

Authors:  L B Krause; S Shuster
Journal:  Lancet       Date:  1984-10-20       Impact factor: 79.321

Review 3.  Urticaria. An updated review.

Authors:  E W Monroe; H E Jones
Journal:  Arch Dermatol       Date:  1977-01

4.  Histamine skin sensitivity and blood histamine in patients with urticaria.

Authors:  D N Prasad; S S Gambhir; G Singh; S K Bhattacharya; P K Das
Journal:  Int Arch Allergy Appl Immunol       Date:  1967

5.  Responses of skin blood vessels to bradykinin, histamine and 5-hydroxytryptamine.

Authors:  M Greaves; S Shuster
Journal:  J Physiol       Date:  1967-11       Impact factor: 5.182

6.  The effects of astemizole on histamine-induced weal and flare.

Authors:  D N Bateman; P H Chapman; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  Histamine weal formation and absorption in man.

Authors:  J Cook; S Shuster
Journal:  Br J Pharmacol       Date:  1980-08       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.